BIONEER CORPORATION

Bioneer's 'CosmeRNA' Secures Key Ingredient Patent Approval in Japan,
Paving the Way for Aggressive Entry into the Local Hair Loss Cosmetics Market

​

The core ingredient of Bioneer's hair loss cosmetics brand, CosmeRNA, has received a patent approval in Japan, following similar approvals in South Korea, China, Australia, and Russia. This milestone is expected to significantly accelerate Bioneer's entry into the Japanese hair loss cosmetics market.

The patented ingredient is based on Bioneer's proprietary SAMiRNA platform technology, which has been applied to create a composition designed to promote hair and scalp care. Products utilizing this technology, such as the CosmeRNA ARI Anti-Hair Loss Tonic, have demonstrated outstanding efficacy in fundamentally improving scalp and hair health. This technological innovation was recognized globally when the product won the Best Hair Product Award at the 2024 Cosmoprof, one of the world's most prestigious cosmetics exhibitions.

According to TPC Marketing Research, a prominent Japanese market research firm, Japan is the world's third-largest hair loss cosmetics market, valued at approximately 5 trillion KRW (roughly 3.8 billion USD) as of 2023, with steady annual growth. Japanese consumers are known for their strong preference for high-quality, safe products and exhibit high loyalty to brands with proven effectiveness. Bioneer plans to leverage this latest patent approval to emphasize its scientific data, credible certifications, and clinically validated efficacy to cater to these consumer preferences.

As of January 2024, CosmeRNA products have been officially launched and are available for purchase on Amazon Japan. Looking ahead, Bioneer plans to expand its online sales through major Japanese e-commerce platforms such as Amazon Japan and Rakuten, starting in 2025. Additionally, the company aims to strengthen its foothold by forming strategic partnerships with local distributors to drive sales growth within Japan.

To further establish trust and brand recognition, Bioneer will collaborate with influencers and celebrities in the medical and cosmetic fields, showcasing the product’s effectiveness through expert endorsements. The company also intends to actively participate in local exhibitions and trade shows to highlight the innovative technology and distinctive ingredients that set CosmeRNA apart.

A representative from Bioneer stated, “Japan is a market with a strong preference for high-quality products, making technological competitiveness a key factor for success. CosmeRNA is not just another hair loss shampoo or superficial hair care product; it offers a scientific approach that fundamentally improves hair and scalp health. We expect to stand out in the Japanese market by building on this patent approval and our previously published clinical studies. By reinforcing our localized strategies and marketing efforts, we aim to firmly establish our presence in Japan.”

This latest patent approval not only highlights Bioneer's advanced technology but also signals a significant step forward in the company's global ambitions to revolutionize hair and scalp care.